BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31472323)

  • 1. Potential of epigenetic events in human thyroid cancer.
    Ahmed AA; Essa MEA
    Cancer Genet; 2019 Nov; 239():13-21. PubMed ID: 31472323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic modifications in human thyroid cancer.
    Faam B; Ghaffari MA; Ghadiri A; Azizi F
    Biomed Rep; 2015 Jan; 3(1):3-8. PubMed ID: 25469237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
    Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
    JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic modification and BRAF gene mutation in thyroid carcinoma.
    Huang G; Chen J; Zhou J; Xiao S; Zeng W; Xia J; Zeng X
    Cancer Cell Int; 2021 Dec; 21(1):687. PubMed ID: 34923978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.
    Mancikova V; Buj R; Castelblanco E; Inglada-Pérez L; Diez A; de Cubas AA; Curras-Freixes M; Maravall FX; Mauricio D; Matias-Guiu X; Puig-Domingo M; Capel I; Bella MR; Lerma E; Castella E; Reverter JL; Peinado MÁ; Jorda M; Robledo M
    Int J Cancer; 2014 Aug; 135(3):598-610. PubMed ID: 24382797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered Epigenetic Mechanisms in Thyroid Cancer Subtypes.
    Zarkesh M; Zadeh-Vakili A; Azizi F; Foroughi F; Akhavan MM; Hedayati M
    Mol Diagn Ther; 2018 Feb; 22(1):41-56. PubMed ID: 28986854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epigenetic landscape of differentiated thyroid cancer.
    Asa SL; Ezzat S
    Mol Cell Endocrinol; 2018 Jul; 469():3-10. PubMed ID: 28711609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics in Medullary Thyroid Cancer: From Pathogenesis to Targeted Therapy.
    Vitale G; Dicitore A; Messina E; Sciammarella C; Faggiano A; Colao A
    Recent Pat Anticancer Drug Discov; 2016; 11(3):275-82. PubMed ID: 27306881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics of ovarian cancer: from the lab to the clinic.
    Asadollahi R; Hyde CA; Zhong XY
    Gynecol Oncol; 2010 Jul; 118(1):81-7. PubMed ID: 20421130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic modulators of thyroid cancer.
    Rodríguez-Rodero S; Delgado-Álvarez E; Díaz-Naya L; Martín Nieto A; Menéndez Torre E
    Endocrinol Diabetes Nutr; 2017 Jan; 64(1):44-56. PubMed ID: 28440770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of RET receptor tyrosine kinase and non-coding RNAs in MTC.
    Joo LJS; Zhao JT; Gild ML; Glover AR; Sidhu SB
    Mol Cell Endocrinol; 2018 Jul; 469():48-53. PubMed ID: 28315378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers.
    Puneet ; Kazmi HR; Kumari S; Tiwari S; Khanna A; Narayan G
    Pathol Oncol Res; 2018 Oct; 24(4):757-770. PubMed ID: 29552712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new insight on reciprocal relationship between microRNA expression and epigenetic modifications in human lung cancer.
    Sheervalilou R; Shirvaliloo S; Fekri Aval S; Khamaneh AM; Sharifi A; Ansarin K; Zarghami N
    Tumour Biol; 2017 May; 39(5):1010428317695032. PubMed ID: 28468581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer.
    Sharma A; Heuck CJ; Fazzari MJ; Mehta J; Singhal S; Greally JM; Verma A
    Wiley Interdiscip Rev Syst Biol Med; 2010; 2(6):654-69. PubMed ID: 20890963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma.
    Syren P; Andersson R; Bauden M; Ansari D
    Scand J Gastroenterol; 2017; 52(6-7):668-673. PubMed ID: 28301276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent epigenetic inactivation of RASSF10 in thyroid cancer.
    Schagdarsurengin U; Richter AM; Wöhler C; Dammann RH
    Epigenetics; 2009 Nov; 4(8):571-6. PubMed ID: 19934646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of PTEN gene methylation with genetic alterations in the phosphatidylinositol 3-kinase/AKT signaling pathway in thyroid tumors.
    Hou P; Ji M; Xing M
    Cancer; 2008 Nov; 113(9):2440-7. PubMed ID: 18831514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene methylation in thyroid tumorigenesis.
    Xing M
    Endocrinology; 2007 Mar; 148(3):948-53. PubMed ID: 16946009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation in thyroid cancer.
    Zafon C; Gil J; Pérez-González B; Jordà M
    Endocr Relat Cancer; 2019 Jul; 26(7):R415-R439. PubMed ID: 31035251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.